Publication: 3377

Publication: 3377

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients (Alliance)

DOI

URL

Google Scholar

Citation:: European Journal of Cancer vol 138 (Supplement 2) S9-S10

Meeting Instance:: ENA / AACR - MTCT 2020
Year:: 2020
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3232

Program:: TRP
Primary Committee:: PPP
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, UG1CA233253, UG1CA233327, UG1CA233373, São Paulo Research Foundation-FAPESP (2018/04491-2)

Corr. Author:
Authors:: Federico Innocenti Jin Wang Alexander B. Sibley Chen Jiang Amy S. Etheridge Fei Shen Jai N. Patel Daniel L. Hertz Elizabeth Claire Dees Howard L. McLeod Monica Bertagnolli Hope Rugo Hedy L. Kindler William Kevin Kelly Mark J. Ratain Deanna L. Kroetz Kouros Owzar Bryan Schneider Danyu Lin Júlia C.F. Quintanilha.

Networks:

Study
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-40502, CALGB-40503, CALGB-80303, CALGB-90401
Phases:: 3

Keywords:: Bevacizumab, hypertension, proteinuria.